| Naziv: | Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics |
Autori: | Marković, Srđan   ; Kralj, Ðorđe; Svorcan, Petar ; Knežević-Ivanovski, Tamara; Odanović, Olga; Obradović, Sanja; Homšek, Ana ; Jovanović, Marija ; Savić, Rada; Vučićević, Katarina |
Godina: | 2024 |
Publikacija: | Pharmaceutics |
ISSN: | 1999-4923 Pharmaceutics Pretraži identifikator |
Izdavač: | Basel, Switzerland : MDPI |
Tip rezultata: | Naučni članak |
Kolacija: | vol. 16 br. 12 str. 1629 |
DOI: | 10.3390/pharmaceutics16121629 |
WoS-ID: | 001383959700001 |
Scopus-ID: | 2-s2.0-85213373736 |
PMID: | 39771608 |
PMCID: | PMC11677246 |
URI: | https://farfar.pharmacy.bg.ac.rs/handle/123456789/5892
https://enauka.gov.rs/handle/123456789/958470 |
URL: | https://www.mdpi.com/1999-4923/16/12/1629 |
Projekat: | optYmAb - Improving Clinical Outcomes with Precision Dosing in Patients with Inflammatory Bowel Disease Through Investigating Variability of Monoclonal Antibodies Based on Population Pharmacokinetic-Pharmacodynamic Modeling |
M-kategorija: | 21M21 - Rad u vrhunskom međ. časopisu |
